Pierre R. Breber - 30 Sep 2025 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Jinho Joo, Attorney-in-Fact
Issuer symbol
CLX
Transactions as of
30 Sep 2025
Transactions value $
$0
Form type
4
Filing time
02 Oct 2025, 16:17:45 UTC
Previous filing
05 Sep 2025
Next filing
01 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Breber Pierre R Director 1221 BROADWAY, OAKLAND By Jinho Joo, Attorney-in-Fact 02 Oct 2025 0001594960

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLX Common Stock 9K 30 Sep 2025 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +5.21 +1.05% $0.00 502 29 Aug 2025 Common Stock 5.21 Direct F2, F3, F4
transaction CLX Deferred Stock Units Award $0 +264 +52.48% $0.00 766 30 Sep 2025 Common Stock 264 Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Indirectly owned through family trust.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.